SGT2 Antibody

What is SGT2/SGTB and what is its biological significance?

SGT2/SGTB is a molecular adaptor protein involved in numerous cellular processes, particularly in protein folding pathways. It functions primarily by enabling molecular adaptor activity and plays crucial roles in chaperone-mediated protein folding, posttranslational protein targeting to endoplasmic reticulum membranes, and the ubiquitin-dependent ERAD (Endoplasmic Reticulum-Associated Degradation) pathway . Research indicates that SGT2 interacts with molecular chaperones, bringing them together to execute specific chaperoning functions, particularly in partnership with proteins like Mdy2 . The protein is predicted to be part of the TRC (Transmembrane Recognition Complex) and demonstrates activity primarily in cellular membranes .

What are the molecular characteristics of SGT2/SGTB?

SGT2/SGTB has an observed molecular weight of approximately 36 kDa on Western blots, though its calculated molecular weight is 57,768 Da . This discrepancy between observed and calculated molecular weights is not uncommon for proteins and may result from post-translational modifications or structural properties affecting migration during gel electrophoresis. SGT2 contains a TPR (tetratricopeptide repeat) domain that is critical for protein-protein interactions, particularly with molecular chaperones . The protein's structure includes distinct N-terminal and C-terminal regions that serve different functions in its interactions with partner proteins and chaperones .

How does SGT2/SGTB interact with molecular chaperone networks?

SGT2/SGTB forms protein complexes with molecular chaperones including YDJ1 (a heat shock protein 40 homolog) and potentially interacts with other chaperones like Ssa1 and Mdy2 . These interactions suggest that SGT2 functions as part of a larger chaperoning network that coordinates protein folding, quality control, and targeting. Experimental evidence indicates that SGT2 and Mdy2 bring molecular chaperones together to accomplish specific cellular functions related to protein homeostasis . The TPR domain within SGT2 is particularly important for these chaperone interactions, as demonstrated through domain disruption experiments .

What types of SGT2/SGTB antibodies are available for research?

Research-grade anti-SGT2/SGTB antibodies are typically generated in rabbit hosts and are available as polyclonal preparations . These antibodies are produced using various immunogens, including E. coli-derived human SGT2/SGTB recombinant protein (specifically from positions Q20-A268 in some commercial preparations) . Both full-length and domain-specific antibodies may be available, though the search results primarily mention polyclonal antibodies against the whole protein. These antibodies undergo rigorous validation to ensure specificity and minimal cross-reactivity with other proteins .

How are SGT2/SGTB antibodies prepared and validated?

The preparation of antibodies against SGT2/SGTB typically follows standard immunological protocols. For example, researchers express the full-length SGT2 or specific domains in bacterial systems, purify the recombinant proteins, and use them as antigens to immunize rabbits . After multiple immunization boosts (at least three in some protocols), antiserum is collected and may undergo further purification steps .

Validation of SGT2/SGTB antibodies includes multiple assays to ensure specificity and sensitivity:

• Western blot analysis against known positive controls (e.g., human HepG2 cell lysates and rat brain tissue lysates)

• ELISA testing to determine binding affinity and specificity

• Cross-reactivity testing against related proteins to confirm specificity

• Immunohistochemistry on tissue arrays when applicable

Commercial antibodies may undergo additional validation processes to guarantee performance across multiple applications and sample types.

What are the primary research applications for SGT2/SGTB antibodies?

SGT2/SGTB antibodies are validated and recommended for several research applications:

• Western Blot (WB): The most common application, used to detect SGT2/SGTB protein in cell or tissue lysates, with recommended working dilutions of 0.25-0.5 μg/ml for human and rat samples .

• ELISA: For quantitative detection of SGT2/SGTB in solution, with typical working dilutions of 0.1-0.5 μg/ml .

• Protein Interaction Studies: Used in immunoprecipitation and pull-down assays to study SGT2's interactions with chaperone proteins like YDJ1 .

• Yeast Two-Hybrid Analysis: While not directly using the antibody, this technique complements antibody-based approaches for studying SGT2 protein-protein interactions .

What is the recommended protocol for Western blot analysis with SGT2/SGTB antibodies?

Based on validated protocols, the following methodology is recommended for Western blot analysis of SGT2/SGTB:

• Sample Preparation: Prepare cell or tissue lysates under reducing conditions. Load approximately 30 μg of protein per lane .

• Gel Electrophoresis: Perform SDS-PAGE using a 5-20% gradient gel at 70V for stacking and 90V for resolving, running for 2-3 hours .

• Transfer: Transfer proteins to a nitrocellulose membrane at 150 mA for 50-90 minutes .

• Blocking: Block the membrane with 5% non-fat milk in TBS for 1.5 hours at room temperature .

• Primary Antibody Incubation: Incubate with anti-SGT2/SGTB antibody at 0.5 μg/ml overnight at 4°C .

• Washing: Wash three times with TBS-0.1% Tween, 5 minutes each .

• Secondary Antibody: Incubate with goat anti-rabbit IgG-HRP at 1:5000 dilution for 1.5 hours at room temperature .

• Detection: Develop using an Enhanced Chemiluminescent detection system .

Expected results: A specific band for SGT2/SGTB should be detected at approximately 36 kDa, though the calculated size is 34 kDa .

How can domain-specific functions of SGT2/SGTB be investigated?

Researchers can investigate domain-specific functions of SGT2/SGTB through several sophisticated approaches:

• Domain Truncation Studies: Engineering truncated versions of SGT2 (such as N-terminal deletion, C-terminal deletion, or TPR domain disruption) for expression studies and functional analysis . This approach helps identify which domains are essential for specific protein-protein interactions.

• Site-Directed Mutagenesis: Introducing specific mutations within functional domains to assess their impact on SGT2's interactions with chaperones and other proteins.

• Domain Swapping: Constructing chimeric proteins where SGT2 domains are swapped with corresponding domains from related proteins to investigate functional conservation.

• GST Pull-Down Assays: Using GST-tagged full-length or truncated SGT2 constructs to identify differential binding partners of specific domains .

• Yeast Two-Hybrid Analysis: Screening for interacting proteins using domain-specific constructs of SGT2 as bait .

What techniques are most effective for studying SGT2/SGTB protein complexes?

Several complementary techniques have proven effective for studying SGT2/SGTB protein complexes:

• Affinity Purification coupled with Mass Spectrometry (AP-MS): Allows for unbiased identification of protein complex components.

• Co-Immunoprecipitation (Co-IP): Using SGT2/SGTB antibodies to pull down the protein along with its interacting partners from cell lysates.

• GST Pull-Down Assays: As demonstrated in research, GST-tagged SGT2 or Mdy2 can be used to identify direct protein-protein interactions .

• Yeast Two-Hybrid (Y2H) Screening: Effective for identifying binary interactions between SGT2 and other proteins, as was used to discover the interaction between Sgt2 and Mdy2 .

• Bimolecular Fluorescence Complementation (BiFC): For visualizing protein-protein interactions in living cells.

• Proximity Labeling Techniques: Methods like BioID or APEX can identify proteins in close proximity to SGT2 in living cells.

What are common issues in SGT2/SGTB antibody experiments?

Several challenges commonly arise when working with SGT2/SGTB antibodies:

• Multiple Bands on Western Blots: This may result from post-translational modifications, alternative splicing variants, or partial degradation of SGT2/SGTB. Control experiments with known positive samples (e.g., HepG2 cell lysates) can help identify the correct band .

• Low Signal Intensity: May result from insufficient protein in samples, suboptimal antibody concentration, or inefficient transfer. Increasing protein load or antibody concentration, or optimizing transfer conditions can help resolve this issue.

• Non-specific Binding: Can be addressed by optimizing blocking conditions (increasing blocking agent concentration or time) and ensuring appropriate antibody dilutions.

• Cross-reactivity: While SGT2/SGTB antibodies are designed to minimize cross-reactivity , validation in your specific experimental system is always recommended through appropriate controls.

• Inconsistent Results: May arise from variations in experimental conditions or sample preparation. Standardizing protocols and including internal controls can improve reproducibility.

What controls are essential for SGT2/SGTB antibody experiments?

Proper controls are critical for ensuring the validity and interpretability of SGT2/SGTB antibody experiments:

• Positive Controls: Include samples known to express SGT2/SGTB, such as human HepG2 whole cell lysates or rat brain tissue lysates .

• Negative Controls: Samples known not to express the target protein, or samples from SGT2/SGTB knockout models.

• Primary Antibody Controls: Omitting the primary antibody while maintaining all other experimental conditions to assess non-specific binding of the secondary antibody.

• Blocking Peptide Controls: Pre-incubation of the antibody with the immunogenic peptide should abolish specific binding.

• Loading Controls: Detection of housekeeping proteins (such as GAPDH, β-actin) to ensure equal loading and transfer efficiency in Western blots.

• Recombinant Protein Standard: Including purified recombinant SGT2/SGTB as a size reference and positive control.

How might SGT2/SGTB antibodies contribute to understanding protein quality control mechanisms?

SGT2/SGTB antibodies offer powerful tools for investigating protein quality control pathways:

• Chaperone Network Mapping: By using SGT2/SGTB antibodies in co-immunoprecipitation experiments, researchers can map the dynamic interactions within chaperone networks under different cellular stress conditions.

• Stress Response Studies: Tracking changes in SGT2/SGTB localization, expression, and interactions during various cellular stresses (heat shock, oxidative stress, ER stress) can reveal its role in adaptive responses.

• ERAD Pathway Investigation: Since SGT2/SGTB is implicated in the ubiquitin-dependent ERAD pathway , antibodies can help elucidate its specific role in directing misfolded proteins for degradation.

• TRC Complex Studies: Investigating SGT2/SGTB's function within the TRC complex may illuminate mechanisms of membrane protein insertion and quality control .

• Therapeutic Target Potential: Understanding SGT2/SGTB's role in protein homeostasis may reveal new therapeutic approaches for diseases associated with protein misfolding.